Content about NEW CASTLE

August 30, 2012

ScripsAmerica last week announced that the company has secured $1 million in financing which it will use to develop, manufacture and distribute its RapiMed brand of children's pain reliever and other core business products.

NEW CASTLE, Del. — ScripsAmerica last week announced that the company has secured $1 million in financing, which it will use to develop, manufacture and distribute its RapiMed brand of children's pain reliever and other core business products.